Clinical Trials on Cardiac Rehabilitation Program Following the Management of ACS in Patients Presenting With SCAD in Mexico
Total 0 results
Nothing found
Sponsors and Collaborators
- Manmohan Cardiothoracic Vascular and Transplant Center
- Korrus Inc.
- Walgreens Co.
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- Fundación Pública Andaluza Progreso y Salud
- IRCCS Don Gnocchi, Milano, Italy
- King Baudouin Foundation
- Ana Paula Costella
- Edanz Group Japan Ltd
- Army Hospital, Percy
- Frankel, Amylynne, M.D.
- Pharmaspecific
- Ruba Musharbash Nutrition Consultancy Center
- Michael J. Wesley, PhD
- Gulsah Ilhan
- Center for Rare Neurological Diseases, Norcross, GA
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- Laboratorios Viñas, S.A.
- HeartPoint Global
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- View Full List
Medical Conditions
- Menopause
- Facial Involvement
- Malignant Intracranial Germ Cell Tumor
- Gastroenteritis Rotavirus
- Impairment, Coordination
- Lung Neuroendocrine Tumor
- Brain Arteriovenous Malformation
- Uncontrolled Type 2 Diabetes Mellitus
- Coagulation Disorder Neonatal
- Developmental Language Disorder and Language Impairment
- Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
- Cardiovascular Outcomes
- Localized Unresectable Adult Primary Liver Cancer
- Cognitive Function, Social 1
- Paralysis of Vocal Cords or Larynx
- Ankylosed Teeth
- Ann Arbor Stage IVB Hodgkin Lymphoma
- Pelvis Tumors
- Severe Atopic Dermatitis
- Kidney Damage
- View Full List
Drug Interventions
- Exendin 9-39
- Lidocaine/ ketamine
- Dexmedetomidine
- Insulin
- Methotrexate
- Ozanimod
- Extended release guanfacine
- Miglustat
- Thiotepa
- 5-Fluorouracil
- Apremilast
- Transdermal estradiol
- Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
- CD25 treatment
- FHND5071
- Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
- Interleukin-2
- Interferon beta-1b (Betaferon, BAY86-5046)
- Rituximab plus CHOP
- LDEPA
- View Full List
CROs by country
- Contract Research Organizations in Colombia
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Egypt
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in Greece
- Contract Research Organizations in India
- Contract Research Organizations in Liberia
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Qatar
- Contract Research Organizations in South Africa
- Contract Research Organizations in Venezuela
- CRO list by country